MANCHESTER, England--(BUSINESS WIRE)--Synexus’ Chris Hannigan will present his vision for how the clinical trials industry must respond to the changing landscape faced by the pharmaceutical sector and embrace innovative practices to improve the speed of clinical trials, rein in costs and increase the statistical power of the results particularly in Phase II.
